The average curcumin particle size in Theracurmin is 0.19 μm, over 100 times smaller than curcumin powder, which has an average particle size of 22.75 μm. These microscopic particles are obtained by mixing curcumin powder with all-natural emulsifiers, including gum from the Indian ghatti tree. This mixture is then ground by a wet grinding mill. To make the curcumin water soluble, it is dispersed evenly through the emulsifiers by homogenization, creating a colloidal suspension that is easily absorbed by the digestive tract. The result is a dramatic increase in the level of curcumin measured in the blood stream. When an oral dose of Theracurmin was tested in rats, the blood concentration was measured over time to produce a graph. The area under the curve (AUC), which reflects the total bioavailability, was found to be more than 40 times higher than that of curcumin powder. Then, healthy human volunteers were given an oral dose of either 30 mg curcumin powder or 30 mg Theracurmin. The bioavailability of Theracurmin was 300 times higher than that of curcumin powder, as measured by AUC (Sasaki). When compared to equal doses of other enhanced curcumin preparations, Theracurmin produced the highest AUC blood levels: four times greater than phosphatidylcholine-bound curcumin. Note that this measurement includes all the curcuminoids in the blood, including the free curcumin plus its metabolites, which have already been metabolized in the liver and are far less active than free curcumin. The only curcumin supplement that actually increased the amount of free curcumin was Theracurmin. Suggested Usage: 1 capsule 2 times per day or as directed by a health professional. Keep out of reach of children. Additional information Consult a health care practitioner prior to use if you are taking antiplatelet medication.